help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KING, T. E.
Right arrow Articles by CHERNIACK, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KING, T. E., JR.
Right arrow Articles by CHERNIACK, R. M.

Am. J. Respir. Crit. Care Med., Volume 164, Number 7, October 2001, 1171-1181

Predicting Survival in Idiopathic Pulmonary Fibrosis
Scoring System and Survival Model

TALMADGE E. KING JR., JANET A. TOOZE, MARVIN I. SCHWARZ, KEVIN R. BROWN, and REUBEN M. CHERNIACK

Departments of Medicine and Divisions of Pulmonary and Critical Care Medicine, San Francisco General Hospital, and the University of California, San Francisco, San Francisco, California; National Jewish Medical and Research Center, and the University of Colorado Health Sciences Center, Denver, Colorado

Our purpose was to identify clinical, radiological and physiological (CRP) determinants of survival and to develop a CRP scoring system that predicts survival in newly diagnosed cases of idiopathic pulmonary fibrosis (IPF). The study population consisted of 238 patients with biopsy confirmed usual interstitial pneumonia. For each patient, clinical manifestations, chest radiographs, and pulmonary physiology were prospectively assessed. We used Cox proportional-hazards models to assess the effect of these parameters on survival. The effects of age and smoking were included in the analysis. Survival was related to age, smoking status (longer in current smokers), clubbing, the extent of interstitial opacities and presence of pulmonary hypertension on the chest radiograph, reduced lung volume, and abnormal gas exchange during maximal exercise. A mathematical CRP score for predicting survival was derived from these parameters. We showed that this CRP score correlated with the extent and severity of the important histopathologic features of IPF, i.e., fibrosis, cellularity, the granulation/connective tissue deposition, and the total pathologic derangement. Using these models, clinicians are in a better position to provide prognostic information to patients with IPF and to improve the selection of the most appropriate patients for lung transplantation or other standard or novel therapeutic interventions.




This article has been cited by other articles:


Home page
 Am. J. Respir. Cell Mol. Bio.Home page
S.-I. Cha, S. D. Groshong, S. K. Frankel, B. L. Edelman, G. P. Cosgrove, J. L. Terry-Powers, L. K. Remigio, D. Curran-Everett, K. K. Brown, C. D. Cool, et al.
Compartmentalized Expression of c-FLIP in Lung Tissues of Patients with Idiopathic Pulmonary Fibrosis
Am. J. Respir. Cell Mol. Biol., February 1, 2010; 42(2): 140 - 148.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
V. Cottin, J. Le Pavec, G. Prevot, H. Mal, M. Humbert, G. Simonneau, J-F. Cordier, and GERM"O"P
Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome
Eur. Respir. J., January 1, 2010; 35(1): 105 - 111.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
E. R. F. Perez, C. E. Daniels, D. R. Schroeder, J. St. Sauver, T. E. Hartman, B. J. Bartholmai, E. S. Yi, and J. H. Ryu
Incidence, Prevalence, and Clinical Course of Idiopathic Pulmonary Fibrosis: A Population-Based Study
Chest, January 1, 2010; 137(1): 129 - 137.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
J M Harris, I D A Johnston, R Rudd, A J N. Taylor, and P Cullinan
Cryptogenic fibrosing alveolitis and lung cancer: the BTS study
Thorax, January 1, 2010; 65(1): 70 - 76.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. J. Swigris, J. Swick, F. S. Wamboldt, D. Sprunger, R. du Bois, A. Fischer, G. P. Cosgrove, S. K. Frankel, E. R. Fernandez-Perez, D. Kervitsky, et al.
Heart Rate Recovery After 6-Min Walk Test Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis
Chest, September 1, 2009; 136(3): 841 - 848.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. J. Lederer, P. L. Enright, S. M. Kawut, E. A. Hoffman, G. Hunninghake, E. J. R. van Beek, J. H. M. Austin, R. Jiang, G. S. Lovasi, and R. G. Barr
Cigarette Smoking Is Associated with Subclinical Parenchymal Lung Disease: The Multi-Ethnic Study of Atherosclerosis (MESA)-Lung Study
Am. J. Respir. Crit. Care Med., September 1, 2009; 180(5): 407 - 414.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. Mejia, G. Carrillo, J. Rojas-Serrano, A. Estrada, T. Suarez, D. Alonso, E. Barrientos, M. Gaxiola, C. Navarro, and M. Selman
Idiopathic Pulmonary Fibrosis and Emphysema: Decreased Survival Associated With Severe Pulmonary Arterial Hypertension
Chest, July 1, 2009; 136(1): 10 - 15.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
B. W. Kinder, K. K. Brown, F. X. McCormack, J. H. Ix, A. Kervitsky, M. I. Schwarz, and T. E. King Jr
Serum Surfactant Protein-A Is a Strong Predictor of Early Mortality in Idiopathic Pulmonary Fibrosis
Chest, June 1, 2009; 135(6): 1557 - 1563.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. Prasse, C. Probst, E. Bargagli, G. Zissel, G. B. Toews, K. R. Flaherty, M. Olschewski, P. Rottoli, and J. Muller-Quernheim
Serum CC-Chemokine Ligand 18 Concentration Predicts Outcome in Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., April 15, 2009; 179(8): 717 - 723.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. Moeller, S. E. Gilpin, K. Ask, G. Cox, D. Cook, J. Gauldie, P. J. Margetts, L. Farkas, J. Dobranowski, C. Boylan, et al.
Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., April 1, 2009; 179(7): 588 - 594.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. D. Fell, L. X. Liu, C. Motika, E. A. Kazerooni, B. H. Gross, W. D. Travis, T. V. Colby, S. Murray, G. B. Toews, F. J. Martinez, et al.
The Prognostic Value of Cardiopulmonary Exercise Testing in Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., March 1, 2009; 179(5): 402 - 407.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. Ferreira, C. Garvey, G. L. Connors, L. Hilling, J. Rigler, S. Farrell, C. Cayou, C. Shariat, and H. R. Collard
Pulmonary Rehabilitation in Interstitial Lung Disease: Benefits and Predictors of Response
Chest, February 1, 2009; 135(2): 442 - 447.
[Abstract] [Full Text] [PDF]

Home page
 ACCP Pulmonary Med Brd RevHome page
H. D. Tazelaar
Pathology of Diffuse and Neoplastic Disease
ACCP Pulmonary Med Brd Rev, January 1, 2009; 25(0): 501 - 512.
[Full Text] [PDF]

Home page
 ACCP Pulmonary Med Brd RevHome page
J. P. Lynch III
Idiopathic Pulmonary Fibrosis, Nonspecific Interstitial Pneumonia/Fibrosis, and Sarcoidosis
ACCP Pulmonary Med Brd Rev, January 1, 2009; 25(0): 635 - 686.
[Full Text] [PDF]

Home page
 RadiologyHome page
A. Devaraj, A. U. Wells, M. G. Meister, T. J. Corte, and D. M. Hansell
The Effect of Diffuse Pulmonary Fibrosis on the Reliability of CT Signs of Pulmonary Hypertension
Radiology, December 1, 2008; 249(3): 1042 - 1049.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
A U Wells, N Hirani, and on behalf of the BTS Interstitial Lung Disease Gui
Interstitial lung disease guideline
Thorax, September 1, 2008; 63(Suppl_5): v1 - v58.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
J. Behr and J. H. Ryu
Pulmonary hypertension in interstitial lung disease
Eur. Respir. J., June 1, 2008; 31(6): 1357 - 1367.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. Strange and J. R. Seibold
Scleroderma Lung Disease: "If You Don't Know Where You Are Going, Any Road Will Take You There"
Am. J. Respir. Crit. Care Med., June 1, 2008; 177(11): 1178 - 1179.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
N. S. L. Goh, S. R. Desai, S. Veeraraghavan, D. M. Hansell, S. J. Copley, T. M. Maher, T. J. Corte, C. R. Sander, J. Ratoff, A. Devaraj, et al.
Interstitial Lung Disease in Systemic Sclerosis: A Simple Staging System
Am. J. Respir. Crit. Care Med., June 1, 2008; 177(11): 1248 - 1254.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
G. Trujillo, E. C. O'Connor, S. L. Kunkel, and C. M. Hogaboam
A Novel Mechanism for CCR4 in the Regulation of Macrophage Activation in Bleomycin-Induced Pulmonary Fibrosis
Am. J. Pathol., May 1, 2008; 172(5): 1209 - 1221.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
C. E. Papadopoulos, G. Pitsiou, T. D. Karamitsos, H. I. Karvounis, T. Kontakiotis, G. Giannakoulas, G. K. Efthimiadis, P. Argyropoulou, G. E. Parharidis, and D. Bouros
Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler echocardiographic study
Eur. Respir. J., April 1, 2008; 31(4): 701 - 706.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
T J Williams and J W Wilson
Challenges in pulmonary fibrosis: 7 {middle dot} Novel therapies and lung transplantation
Thorax, March 1, 2008; 63(3): 277 - 284.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. M. Antoniou, D. M. Hansell, M. B. Rubens, K. Marten, S. R. Desai, N. M. Siafakas, A. G. Nicholson, R. M. du Bois, and A. U. Wells
Idiopathic Pulmonary Fibrosis: Outcome in Relation to Smoking Status
Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 190 - 194.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. E. King Jr., J. Behr, K. K. Brown, R. M. du Bois, L. Lancaster, J. A. de Andrade, G. Stahler, I. Leconte, S. Roux, and G. Raghu
BUILD-1: A Randomized Placebo-controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., January 1, 2008; 177(1): 75 - 81.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
B. W. Kinder, K. K. Brown, M. I. Schwarz, J. H. Ix, A. Kervitsky, and T. E. King Jr
Baseline BAL Neutrophilia Predicts Early Mortality in Idiopathic Pulmonary Fibrosis
Chest, January 1, 2008; 133(1): 226 - 232.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. R. Hemnes, A. Zaiman, and H. C. Champion
PDE5A inhibition attenuates bleomycin-induced pulmonary fibrosis and pulmonary hypertension through inhibition of ROS generation and RhoA/Rho kinase activation
Am J Physiol Lung Cell Mol Physiol, January 1, 2008; 294(1): L24 - L33.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. F. Shorr, J. L. Wainright, C. S. Cors, C. J. Lettieri, and S. D. Nathan
Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant
Eur. Respir. J., October 1, 2007; 30(4): 715 - 721.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
A. U Wells, A. G Nicholson, and D. M Hansell
Challenges in pulmonary fibrosis {middle dot} 4: Smoking-induced diffuse interstitial lung diseases
Thorax, October 1, 2007; 62(10): 904 - 910.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
I. O. Rosas, P. Ren, N. A. Avila, C. K. Chow, T. J. Franks, W. D. Travis, J. P. McCoy Jr., R. M. May, H.-P. Wu, D. M. Nguyen, et al.
Early Interstitial Lung Disease in Familial Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., October 1, 2007; 176(7): 698 - 705.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
N. M. Patel, D. J. Lederer, A. C. Borczuk, and S. M. Kawut
Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis
Chest, September 1, 2007; 132(3): 998 - 1006.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
G. W. Hunninghake and M. I. Schwarz
State of the Art. Does Current Knowledge Explain the Pathogenesis of Idiopathic Pulmonary Fibrosis?: A Perspective
Proceedings of the ATS, August 15, 2007; 4(5): 449 - 452.
[Abstract] [Full Text] [PDF]

Home page
 ERRHome page
R. M. du Bois
Blocking endothelin: breaking new ground
Eur. Respir. Rev., August 1, 2007; 16(102): 24 - 29.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
D. Kass, R. S. Bridges, A. Borczuk, and S. Greenberg
Methionine Aminopeptidase-2 as a Selective Target of Myofibroblasts in Pulmonary Fibrosis
Am. J. Respir. Cell Mol. Biol., August 1, 2007; 37(2): 193 - 201.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. D. Nathan, P. W. Noble, and R. M. Tuder
Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension: Connecting the Dots
Am. J. Respir. Crit. Care Med., May 1, 2007; 175(9): 875 - 880.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. Alakhras, P. A. Decker, H. F. Nadrous, M. Collazo-Clavell, and J. H. Ryu
Body Mass Index and Mortality in Patients With Idiopathic Pulmonary Fibrosis
Chest, May 1, 2007; 131(5): 1448 - 1453.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. D. Fell and F. J. Martinez
The Impact of Pulmonary Arterial Hypertension on Idiopathic Pulmonary Fibrosis
Chest, March 1, 2007; 131(3): 641 - 643.
[Full Text] [PDF]

Home page
 ChestHome page
S. D. Nathan, O. A. Shlobin, S. Ahmad, S. Urbanek, and S. D. Barnett
Pulmonary Hypertension and Pulmonary Function Testing in Idiopathic Pulmonary Fibrosis
Chest, March 1, 2007; 131(3): 657 - 663.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. Portnoy, K. L. Veraldi, M. I. Schwarz, C. D. Cool, D. Curran-Everett, R. M. Cherniack, T. E. King Jr, and K. K. Brown
Respiratory Bronchiolitis-Interstitial Lung Disease: Long-term Outcome
Chest, March 1, 2007; 131(3): 664 - 671.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. Hamada, S. Nagai, S. Tanaka, T. Handa, M. Shigematsu, T. Nagao, M. Mishima, M. Kitaichi, and T. Izumi
Significance of Pulmonary Arterial Pressure and Diffusion Capacity of the Lung as Prognosticator in Patients With Idiopathic Pulmonary Fibrosis
Chest, March 1, 2007; 131(3): 650 - 656.
[Abstract] [Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
J. H. Ryu, M. J. Krowka, K. L. Swanson, P. A. Pellikka, and M. D. McGoon
Pulmonary Hypertension in Patients With Interstitial Lung Diseases
Mayo Clin. Proc., March 1, 2007; 82(3): 342 - 350.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
H. H. Leuchte, M. El Nounou, J. C. Tuerpe, B. Hartmann, R. A. Baumgartner, M. Vogeser, O. Muehling, and J. Behr
N-terminal Pro-Brain Natriuretic Peptide and Renal Insufficiency as Predictors of Mortality in Pulmonary Hypertension
Chest, February 1, 2007; 131(2): 402 - 409.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
S. Dal Corso, S. R. Duarte, J. A. Neder, C. Malaguti, M. B. de Fuccio, C. A. de Castro Pereira, and L. E. Nery
A step test to assess exercise-related oxygen desaturation in interstitial lung disease
Eur. Respir. J., February 1, 2007; 29(2): 330 - 336.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. Palange, S. A. Ward, K-H. Carlsen, R. Casaburi, C. G. Gallagher, R. Gosselink, D. E. O'Donnell, L. Puente-Maestu, A. M. Schols, S. Singh, et al.
Recommendations on the use of exercise testing in clinical practice
Eur. Respir. J., January 1, 2007; 29(1): 185 - 209.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
W. O. Villalba, P. D. Sampaio-Barros, M. C. Pereira, E. M. F. P. Cerqueira, C. A. Leme Jr, J. F. Marques-Neto, and I. A. Paschoal
Six-Minute Walk Test for the Evaluation of Pulmonary Disease Severity in Scleroderma Patients
Chest, January 1, 2007; 131(1): 217 - 222.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
A U Wells, D M Hansell, and A G Nicholson
What is this thing called CFA?
Thorax, January 1, 2007; 62(1): 3 - 4.
[Full Text] [PDF]

Home page
 ThoraxHome page
R. M Rudd, R. J Prescott, J C Chalmers, I. D A Johnston, and for the Fibrosing Alveolitis Subcommittee of the R
British Thoracic Society Study on cryptogenic fibrosing alveolitis: response to treatment and survival
Thorax, January 1, 2007; 62(1): 62 - 66.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
L Tiitto, R Bloigu, U Heiskanen, P Paakko, V L Kinnula, and R Kaarteenaho-Wiik
Relationship between histopathological features and the course of idiopathic pulmonary fibrosis/usual interstitial pneumonia
Thorax, December 1, 2006; 61(12): 1091 - 1095.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Yamamoto, M. Otani, and M. Otsuki
A new model of chronic pancreatitis in rats.
Am J Physiol Gastrointest Liver Physiol, October 1, 2006; 291(4): G700 - G708.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
G. Raghu, D. Weycker, J. Edelsberg, W. Z. Bradford, and G. Oster
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., October 1, 2006; 174(7): 810 - 816.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. R. Flaherty, A.-C. Andrei, S. Murray, C. Fraley, T. V. Colby, W. D. Travis, V. Lama, E. A. Kazerooni, B. H. Gross, G. B. Toews, et al.
Idiopathic Pulmonary Fibrosis: Prognostic Value of Changes in Physiology and Six-Minute-Walk Test
Am. J. Respir. Crit. Care Med., October 1, 2006; 174(7): 803 - 809.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. J. Lederer, S. M. Arcasoy, J. S. Wilt, F. D'Ovidio, J. R. Sonett, and S. M. Kawut
Six-Minute-Walk Distance Predicts Waiting List Survival in Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., September 15, 2006; 174(6): 659 - 664.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. D. Cool, S. D. Groshong, P. R. Rai, P. M. Henson, J. S. Stewart, and K. K. Brown
Fibroblast Foci Are Not Discrete Sites of Lung Injury or Repair: The Fibroblast Reticulum
Am. J. Respir. Crit. Care Med., September 15, 2006; 174(6): 654 - 658.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
K. M. Antoniou, A. G. Nicholson, M. Dimadi, K. Malagari, P. Latsi, A. Rapti, N. Tzanakis, R. Trigidou, V. Polychronopoulos, and D. Bouros
Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis
Eur. Respir. J., September 1, 2006; 28(3): 496 - 504.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
T. E. King Jr and M. Selman
Introduction
Proceedings of the ATS, June 1, 2006; 3(4): 283 - 284.
[Full Text] [PDF]

Home page
 ChestHome page
Y. S. Wasfi, C. S. Rose, J. R. Murphy, L. J. Silveira, J. C. Grutters, Y. Inoue, M. A. Judson, and L. A. Maier
A New Tool To Assess Sarcoidosis Severity
Chest, May 1, 2006; 129(5): 1234 - 1245.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. H. Leuchte, R. A. Baumgartner, M. E. Nounou, M. Vogeser, C. Neurohr, M. Trautnitz, and J. Behr
Brain Natriuretic Peptide Is a Prognostic Parameter in Chronic Lung Disease
Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 744 - 750.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. J. Lettieri, S. D. Nathan, S. D. Barnett, S. Ahmad, and A. F. Shorr
Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis
Chest, March 1, 2006; 129(3): 746 - 752.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. Raghu, S. T.-Y. Yang, C. Spada, J. Hayes, and C. A. Pellegrini
Sole Treatment of Acid Gastroesophageal Reflux in Idiopathic Pulmonary Fibrosis: A Case Series
Chest, March 1, 2006; 129(3): 794 - 800.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
F. J. Martinez
Idiopathic Interstitial Pneumonias: Usual Interstitial Pneumonia versus Nonspecific Interstitial Pneumonia.
Proceedings of the ATS, January 1, 2006; 3(1): 81 - 95.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
D. S. Kim, H. R. Collard, and T. E. King Jr.
Classification and natural history of the idiopathic interstitial pneumonias.
Proceedings of the ATS, January 1, 2006; 3(4): 285 - 292.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
F. J. Martinez and K. Flaherty
Pulmonary function testing in idiopathic interstitial pneumonias.
Proceedings of the ATS, January 1, 2006; 3(4): 315 - 321.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
N. Walter, H. R. Collard, and T. E. King Jr.
Current perspectives on the treatment of idiopathic pulmonary fibrosis.
Proceedings of the ATS, January 1, 2006; 3(4): 330 - 338.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
R. Pellegrino, G. Viegi, V. Brusasco, R. O. Crapo, F. Burgos, R. Casaburi, A. Coates, C. P. M. van der Grinten, P. Gustafsson, J. Hankinson, et al.
Interpretative strategies for lung function tests
Eur. Respir. J., November 1, 2005; 26(5): 948 - 968.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. P. Steele, M. C. Speer, J. E. Loyd, K. K. Brown, A. Herron, S. H. Slifer, L. H. Burch, M. M. Wahidi, J. A. Phillips III, T. A. Sporn, et al.
Clinical and Pathologic Features of Familial Interstitial Pneumonia
Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1146 - 1152.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
S. D. Nathan
Therapeutic Intervention: Assessing the Role of the International Consensus Guidelines
Chest, November 1, 2005; 128(5_suppl_1): 533S - 539S.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
V. Cottin, H. Nunes, P-Y. Brillet, P. Delaval, G. Devouassoux, I. Tillie-Leblond, D. Israel-Biet, I. Court-Fortune, D. Valeyre, J-F. Cordier, et al.
Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity
Eur. Respir. J., October 1, 2005; 26(4): 586 - 593.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. Strange
Treatment for Secondary Pulmonary Hypertension
Chest, October 1, 2005; 128(4): 1897 - 1898.
[Full Text] [PDF]

Home page
 ChestHome page
L. Tiitto, U. Heiskanen, R. Bloigu, P. Paakko, V. Kinnula, and R. Kaarteenaho-Wiik
Thoracoscopic Lung Biopsy Is a Safe Procedure in Diagnosing Usual Interstitial Pneumonia
Chest, October 1, 2005; 128(4): 2375 - 2380.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
H. F. Nadrous, P. A. Pellikka, M. J. Krowka, K. L. Swanson, N. Chaowalit, P. A. Decker, and J. H. Ryu
Pulmonary Hypertension in Patients With Idiopathic Pulmonary Fibrosis
Chest, October 1, 2005; 128(4): 2393 - 2399.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
M. A Pacanowski and G. W Amsden
Interferon Gamma-1b in the Treatment of Idiopathic Pulmonary Fibrosis
Ann. Pharmacother., October 1, 2005; 39(10): 1678 - 1686.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
H. Date, Y. Tanimoto, K. Goto, I. Yamadori, M. Aoe, Y. Sano, and N. Shimizu
A New Treatment Strategy for Advanced Idiopathic Interstitial Pneumonia*: Living-Donor Lobar Lung Transplantation
Chest, September 1, 2005; 128(3): 1364 - 1370.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. E. King Jr.
Clinical Advances in the Diagnosis and Therapy of the Interstitial Lung Diseases
Am. J. Respir. Crit. Care Med., August 1, 2005; 172(3): 268 - 279.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. Azuma, T. Nukiwa, E. Tsuboi, M. Suga, S. Abe, K. Nakata, Y. Taguchi, S. Nagai, H. Itoh, M. Ohi, et al.
Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., May 1, 2005; 171(9): 1040 - 1047.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
J J Egan, F J Martinez, A U Wells, and T Williams
Lung function estimates in idiopathic pulmonary fibrosis: the potential for a simple classification
Thorax, April 1, 2005; 60(4): 270 - 273.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
I. Ito, S. Nagai, M. Kitaichi, A. G. Nicholson, T. Johkoh, S. Noma, D. S. Kim, T. Handa, T. Izumi, and M. Mishima
Pulmonary Manifestations of Primary Sjogren's Syndrome: A Clinical, Radiologic, and Pathologic Study
Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 632 - 638.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
Y. Jegal, D. S. Kim, T. S. Shim, C.-M. Lim, S. Do Lee, Y. Koh, W. S. Kim, W. D. Kim, J. S. Lee, W. D. Travis, et al.
Physiology Is a Stronger Predictor of Survival than Pathology in Fibrotic Interstitial Pneumonia
Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 639 - 644.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
S. D. Nathan
Lung Transplantation: Disease-Specific Considerations for Referral
Chest, March 1, 2005; 127(3): 1006 - 1016.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. M. Pilewski, L. Liu, A. C. Henry, A. V. Knauer, and C. A. Feghali-Bostwick
Insulin-Like Growth Factor Binding Proteins 3 and 5 Are Overexpressed in Idiopathic Pulmonary Fibrosis and Contribute to Extracellular Matrix Deposition
Am. J. Pathol., February 1, 2005; 166(2): 399 - 407.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
T. S. Hallstrand, L. J. Boitano, W. C. Johnson, C. A. Spada, J. G. Hayes, and G. Raghu
The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis
Eur. Respir. J., January 1, 2005; 25(1): 96 - 103.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. J. Swigris, W. G. Kuschner, J. L. Kelsey, and M. K. Gould
Idiopathic Pulmonary Fibrosis: Challenges and Opportunities for the Clinician and Investigator
Chest, January 1, 2005; 127(1): 275 - 283.
[Abstract] [Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
H. F. Nadrous, J. L. Myers, P. A. Decker, and J. H. Ryu
Idiopathic Pulmonary Fibrosis in Patients Younger Than 50 Years
Mayo Clin. Proc., January 1, 2005; 80(1): 37 - 40.
[Abstract] [PDF]

Home page
 ChestHome page
M. Bonay, C. Bancal, D. de Zuttere, F. Arnoult, G. Saumon, and F. Camus
Normal Pulmonary Capillary Blood Volume in Patients With Chronic Infiltrative Lung Disease and High Pulmonary Artery Pressure
Chest, November 1, 2004; 126(5): 1460 - 1466.
[Abstract] [Full Text] [PDF]

Home page
 ImagingHome page
N J Screaton and T Koh
Emphysema and smoking-related lung diseases
Imaging, October 1, 2004; 16(1): 50 - 60.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
N. S. Hill
Brain Natriuretic Peptide: Is It Helpful in Detecting Pulmonary Hypertension in Fibrotic Lung Disease?
Am. J. Respir. Crit. Care Med., August 15, 2004; 170(4): 352 - 353.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. H. Leuchte, C. Neurohr, R. Baumgartner, M. Holzapfel, W. Giehrl, M. Vogeser, and J. Behr
Brain Natriuretic Peptide and Exercise Capacity in Lung Fibrosis and Pulmonary Hypertension
Am. J. Respir. Crit. Care Med., August 15, 2004; 170(4): 360 - 365.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
G. P. Cosgrove, K. K. Brown, W. P. Schiemann, A. E. Serls, J. E. Parr, M. W. Geraci, M. I. Schwarz, C. D. Cool, and G. S. Worthen
Pigment Epithelium-derived Factor in Idiopathic Pulmonary Fibrosis: A Role in Aberrant Angiogenesis
Am. J. Respir. Crit. Care Med., August 1, 2004; 170(3): 242 - 251.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
G. Raghu, K. K. Brown, W. Z. Bradford, K. Starko, P. W. Noble, D. A. Schwartz, T. E. King Jr., and the Idiopathic Pulmonary Fibrosis Study Group
A Placebo-Controlled Trial of Interferon Gamma-1b in Patients with Idiopathic Pulmonary Fibrosis
N. Engl. J. Med., January 8, 2004; 350(2): 125 - 133.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
V. N. Lama, K. R. Flaherty, G. B. Toews, T. V. Colby, W. D. Travis, Q. Long, S. Murray, E. A. Kazerooni, B. H. Gross, J. P. Lynch III, et al.
Prognostic Value of Desaturation during a 6-Minute Walk Test in Idiopathic Interstitial Pneumonia
Am. J. Respir. Crit. Care Med., November 1, 2003; 168(9): 1084 - 1090.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. Selman
The Spectrum of Smoking-Related Interstitial Lung Disorders: The Never-Ending Story of Smoke and Disease
Chest, October 1, 2003; 124(4): 1185 - 1187.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Cisneros-Lira, M. Gaxiola, C. Ramos, M. Selman, and A. Pardo
Cigarette smoke exposure potentiates bleomycin-induced lung fibrosis in guinea pigs
Am J Physiol Lung Cell Mol Physiol, October 1, 2003; 285(4): L949 - L956.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
N. Kaminski, J. A. Belperio, P. B. Bitterman, L. Chen, S. W. Chensue, A. M.K. Choi, S. Dacic, J. H. Dauber, R. M. du Bois, J. J. Enghild, et al.
Idiopathic Pulmonary Fibrosis
Am. J. Respir. Cell Mol. Biol., September 1, 2003; 29(3): S1 - 105.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. R. Collard, T. E. King Jr., B. B. Bartelson, J. S. Vourlekis, M. I. Schwarz, and K. K. Brown
Changes in Clinical and Physiologic Variables Predict Survival in Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., September 1, 2003; 168(5): 538 - 542.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. R. Flaherty, J. A. Mumford, S. Murray, E. A. Kazerooni, B. H. Gross, T. V. Colby, W. D. Travis, A. Flint, G. B. Toews, J. P. Lynch III, et al.
Prognostic Implications of Physiologic and Radiographic Changes in Idiopathic Interstitial Pneumonia
Am. J. Respir. Crit. Care Med., September 1, 2003; 168(5): 543 - 548.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. I. Latsi, R. M. du Bois, A. G. Nicholson, T. V. Colby, D. Bisirtzoglou, A. Nikolakopoulou, S. Veeraraghavan, D. M. Hansell, and A. U. Wells
Fibrotic Idiopathic Interstitial Pneumonia: The Prognostic Value of Longitudinal Functional Trends
Am. J. Respir. Crit. Care Med., September 1, 2003; 168(5): 531 - 537.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
G. Thabut, H. Mal, Y. Castier, O. Groussard, O. Brugiere, R. Marrash-Chahla, G. Leseche, and M. Fournier
Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis
J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 469 - 475.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
F. Laghi and M. J. Tobin
Disorders of the Respiratory Muscles
Am. J. Respir. Crit. Care Med., July 1, 2003; 168(1): 10 - 48.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Chilosi, V. Poletti, A. Zamo, M. Lestani, L. Montagna, P. Piccoli, S. Pedron, M. Bertaso, A. Scarpa, B. Murer, et al.
Aberrant Wnt/{beta}-Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis
Am. J. Pathol., May 1, 2003; 162(5): 1495 - 1502.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. U. Wells, S. R. Desai, M. B. Rubens, N. S. L. Goh, D. Cramer, A. G. Nicholson, T. V. Colby, R. M. du Bois, and D. M. Hansell
Idiopathic Pulmonary Fibrosis: A Composite Physiologic Index Derived from Disease Extent Observed by Computed Tomography
Am. J. Respir. Crit. Care Med., April 1, 2003; 167(7): 962 - 969.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
N. Mayer-Hamblett, M. Rosenfeld, J. Emerson, C. H. Goss, and M. L. Aitken
Developing Cystic Fibrosis Lung Transplant Referral Criteria Using Predictors of 2-Year Mortality
Am. J. Respir. Crit. Care Med., December 15, 2002; 166(12): 1550 - 1555.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2001 American Thoracic Society 		  SOTA, FL